Jérémie Zerbit
Impact in
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Oncology 5
- COVID-19 and healthcare impacts 2
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Rudy Birsen (4 shared papers)Didier Bouscary (4 shared papers)Isabelle Madelaine (2 shared papers)Justine Decroocq (4 shared papers)Éric Grignano (2 shared papers)Nicolas Chapuis (1 shared paper)Michaëla Fontenay (1 shared paper)Olivier Kosmider (1 shared paper)
- Journals
- Cell Death Discovery (1 paper)Viruses (1 paper)Therapeutic Drug Monitoring (1 paper)Cancer Treatment Reviews (1 paper)The Lancet Haematology (1 paper)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
Jérémie Zerbit
9 papers receiving 152 citations
Peers
Comparison fields: 5 of 52
- Geriatrics and Gerontology 13
- Family Practice 6
- Endocrinology, Diabetes and Metabolism 32
- Infectious Diseases 33
- Toxicology 6
Countries citing papers authored by Jérémie Zerbit
This map shows the geographic impact of Jérémie Zerbit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémie Zerbit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémie Zerbit more than expected).
Fields of papers citing papers by Jérémie Zerbit
This network shows the impact of papers produced by Jérémie Zerbit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémie Zerbit. The network helps show where Jérémie Zerbit may publish in the future.
Co-authors
The 25 scholars most cited alongside Jérémie Zerbit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 38 | |
| 2 | 2022 | 35 | |
| 3 | 2020 | 33 | |
| 4 | 2022 | 15 | |
| 5 | 2020 | 13 | |
| 6 | 2020 | 9 | |
| 7 | 2022 | 6 | |
| 8 | 2014 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 0 |
About Jérémie Zerbit
Jérémie Zerbit is a scholar working on Oncology, Infectious Diseases, Pediatrics, Perinatology and Child Health, Genetics and Pathology and Forensic Medicine, having authored 10 papers that have together received 154 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), COVID-19 and healthcare impacts (2 papers), Pharmaceutical studies and practices (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Geriatrics and Gerontology (13 citations), Family Practice (6 citations), Endocrinology, Diabetes and Metabolism (32 citations), Infectious Diseases (33 citations) and Toxicology (6 citations). Jérémie Zerbit has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Rudy Birsen, Didier Bouscary, Isabelle Madelaine, Justine Decroocq, Éric Grignano, Nicolas Chapuis, Michaëla Fontenay, Olivier Kosmider, Florence Ranchon and Éric Pasmant. Their work appears in journals such as Cell Death Discovery, Viruses, Therapeutic Drug Monitoring, Cancer Treatment Reviews and The Lancet Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.